PSNC sets up Community Pharmacy Brexit Forum

PSNC sets up Community Pharmacy Brexit Forum

July 27 2018 Chief executives of representative bodies involved in community pharmacy and the...

Boots and PDA discuss union recognition, but no agreement as yet

Boots and PDA discuss union recognition, but no agreement as yet

July 26 2018 The Pharmacists’ Defence Association has been holding talks with members of...

Appeal process for overpayment recovery by NHS England to start in August

Appeal process for overpayment recovery by NHS England to start in August

July 26 2018 New regulations introducing an appeals process to challenge NHS England recovering...

MPs hear about community pharmacy role in LTC management

MPs hear about community pharmacy role in LTC management

July 20 2018 Community pharmacy representatives have briefed MPs about the role pharmacy teams...

MHRA launches consultation on implementing FMD safety features

MHRA launches consultation on implementing FMD safety features

July 20 2018 A consultation asking for views on how the safety features required under the...

  • PSNC sets up Community Pharmacy Brexit Forum

    PSNC sets up Community Pharmacy Brexit Forum

    Friday, 27 July 2018 16:04
  • Boots and PDA discuss union recognition, but no agreement as yet

    Boots and PDA discuss union recognition, but no agreement as yet

    Thursday, 26 July 2018 15:19
  • Appeal process for overpayment recovery by NHS England to start in August

    Appeal process for overpayment recovery by NHS England to start in August

    Thursday, 26 July 2018 15:04
  • MPs hear about community pharmacy role in LTC management

    MPs hear about community pharmacy role in LTC management

    Friday, 20 July 2018 16:30
  • MHRA launches consultation on implementing FMD safety features

    MHRA launches consultation on implementing FMD safety features

    Friday, 20 July 2018 14:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a scottish flag image cbApril 11 2018

Payment arrangements for March 2018 have been modified for pharmacy contractors in Scotland, with a temporary change to the dispensing pool payment. In addition, the discount clawback scale has been revised for January to March 2018, and new arrangements are being discussed for April.

The Scottish Executive Health and Social Care Directorate has issued two NHS circulars relating to Drug Tariff changes. The first, PCA(P)(2018)03, says that the Part 11 discount clawback rate to the Drug Tariff shall be reset to 4.31% effective from January 1 2018. This follows a resetting of the discount clawback scale to 6.93% with effect from June 2017.

In addition: “Discussions on the 2018/19 community pharmacy financial settlement are currently ongoing. As such the current remuneration and reimbursement arrangements shall remain in place from 1 April 2018 until a settlement has been reached or until otherwise notified.”

The second NHS circular, PCA(P)(2018)04, says that a temporary dispensing pool balancing payment will apply for the dispensing month of March 2018 only. “The payment to each eligible contractor is calculated as 3% of the base dispensing pool payment – or where it applies the alternative minimum monthly payment. This will be paid as ‘DP_Balance’ adjustment.”

Eligibility for this payment will be for those on the pharmaceutical list as at March 1 2018.

Links:
SEHD: PCA(P)(2018)03  Pharmaceutical services amendments to the drug tariff part 11 discount clawback scale and remuneration and reimbursement arrangements from 1 April 2018            
SEHD: PCA(P)(2018)04  Pharmaceutical services: Drug Tariff part 7: dispensing pool payment     

Business News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...